Moolec Science (MLECW) Cash & Equivalents (2022 - 2026)

Moolec Science has reported Cash & Equivalents for 5 years, with the latest figure at $1.2 million in Q1 2026.

• Quarterly Cash & Equivalents changed N/A year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $767919.0, down 98.55% from the prior year.
• Cash & Equivalents grew to $1.2 million in Q1 2026 per MLECW's latest filing, from $1.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $228.0 million in Q1 2023 and troughed at $767919.0 in Q2 2025.
• A 5-year average of $32.8 million and a median of $4.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents soared 19030.68% in 2023, then sank 98.55% in 2025.
• Over 5 years, Cash & Equivalents stood at $10.4 million in 2022, then surged by 372.37% to $49.3 million in 2023, then climbed by 7.57% to $53.0 million in 2024, then tumbled by 98.11% to $1.0 million in 2025, then rose by 20.0% to $1.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.2 million, $1.0 million, and $767919.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.